Immunohistochemical tracking of an immune response in mammary Paget's disease

Cancer Letters

Volumn 272, Issue 2, 2008, Pages 206-220

  Brunhuber, Thomas ^a   Haybaeck, Johannes ^b   Schäfer, Georg ^a   Mikuz, Gregor ^a   Langhoff, Eric ^d   Saeland, Sem ^e   Lebecque, Serge ^e   Romani, Nikolaus ^c   Obrist, Peter ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Breast; Dendritic cells; Immune response; Immunohistochemistry; Paget disease

Indexed keywords

LANGERIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; PROTEIN P55; PROTEIN S 100; T6 ANTIGEN;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; PAGET NIPPLE DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CASE-CONTROL STUDIES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PAGET'S DISEASE, MAMMARY;

EID: 55949108672     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.07.028     Document Type: Article

References (39)

1. Salvadori B., Fariselli G., and Saccozzi R. Analysis of 100 cases of Paget's disease of the breast. Tumori 62 (1976) 529-535
2. Lammie G.A., Barnes D.M., Millis R.R., and Gullick W.J. An immunohistochemical study of the presence of c-erbB-2 protein in Paget's disease of the nipple. Histopathology 15 (1989) 505-514
3. Vielh P., Validire P., Kheirallah S., Campana F., Fourquet A., and Di Bonito L. Paget's disease of the nipple without clinically and radiologically detectable breast tumor. Histochemical and immunohistochemical study of 44 cases. Pathol. Res. Pract. 189 (1993) 150-155
4. Schelfhout V.R., Coene E.D., Delaey B., Thys S., Page D.L., and De Potter C.R. Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family. J. Natl. Cancer Inst. 92 (2000) 622-628
5. Boon T., Cerottini J.C., Van den E.B., van der B.P., and Van Pel A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12 (1994) 337-365
6. Houghton A.N. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180 (1994) 1-4
7. Bell D., Young J.W., and Banchereau J. Dendritic cells. Anticancer Res 72 (1999) 255-324
8. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9 (1991) 271-296
9. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
10. Rowden G. The Langerhans cell. Crit. Rev. Immunol. 3 (1981) 95-180
11. de Fraissinette A., Schmitt D., and Thivolet J. Langerhans cells of human mucosa. J. Dermatol. 16 (1989) 255-262
12. Holt P.G., Schon-Hegrad M.A., and McMenamin P.G. Dendritic cells in the respiratory tract. Int. Rev. Immunol. 6 (1990) 139-149
13. McWilliam A.S., Nelson D.J., and Holt P.G. The biology of airway dendritic cells. Immunol. Cell Biol. 73 (1995) 405-413
14. Schon-Hegrad M.A., Oliver J., McMenamin P.G., and Holt P.G. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J. Exp. Med. 173 (1991) 1345-1356
15. Valladeau J., Ravel O., Dezutter-Dambuyant C., Moore K., Kleijmeer M., Liu Y., Duvert-Frances V., Vincent C., Schmitt D., Davoust J., Caux C., Lebecque S., and Saeland S. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12 (2000) 71-81
16. Valladeau J., Duvert-Frances V., Pin J.J., Dezutter-Dambuyant C., Vincent C., Massacrier C., Vincent J., Yoneda K., Banchereau J., Caux C., Davoust J., and Saeland S. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 29 (1999) 2695-2704
17. Guermonprez P., Valladeau J., Zitvogel L., Thery C., and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002) 621-667
18. Saint-Vis B., Vincent J., Vandenabeele S., Vanbervliet B., Pin J.J., Ait-Yahia S., Patel S., Mattei M.G., Banchereau J., Zurawski S., Davoust J., Caux C., and Lebecque S. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9 (1998) 325-336
19. Mosialos G., Birkenbach M., Ayehunie S., Matsumura F., Pinkus G.S., Kieff E., and Langhoff E. Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am. J. Pathol. 148 (1996) 593-600
20. Sonderbye L., Magerstadt R., Blatman R.N., Preffer F.I., and Langhoff E. Selective expression of human fascin (p55) by dendritic leukocytes. Adv. Exp. Med. Biol. 417 (1997) 41-46
21. Ross R., Ross X.L., Schwing J., Langin T., and Reske-Kunz A.B. The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells. J. Immunol. 160 (1998) 3776-3782
22. Reichert T.E., Scheuer C., Day R., Wagner W., and Whiteside T.L. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 91 (2001) 2136-2147
23. Miyagi J., Kinjo T., Tsuhako K., Higa M., Iwamasa T., Kamada Y., and Hirayasu T. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology 38 (2001) 355-367
24. Furihata M., Ohtsuki Y., Ido E., Iwata J., Sonobe H., Araki K., Ogoshi S., and Ohmori K. HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma-their distribution in relation to prognosis. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 61 (1992) 409-414
25. Tsujitani S., Kakeji Y., Maehara Y., Sugimachi K., and Kaibara N. Dendritic cells prevent lymph node metastasis in patients with gastric cancer. In Vivo 7 (1993) 233-237
26. Inoue K., Furihata M., Ohtsuki Y., and Fujita Y. Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virchows Arch. A Pathol. Anat. Histopathol. 422 (1993) 351-355
27. Lespagnard L., Gancberg D., Rouas G., Leclercq G., Saint-Aubain S.N., Di Leo A., Piccart M., Verhest A., and Larsimont D. Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int. J. Cancer 84 (1999) 309-314
28. Ambe K., Mori M., and Enjoji M. S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer 63 (1989) 496-503
29. Becker Y. Anticancer role of dendritic cells (DC) in human and experimental cancers-a review. Anticancer Res. 12 (1992) 511-520
30. Bell D., Chomarat P., Broyles D., Netto G., Harb G.M., Lebecque S., Valladeau J., Davoust J., Palucka K.A., and Banchereau J. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 190 (1999) 1417-1426
31. Gabrilovich D.I., Corak J., Ciernik I.F., Kavanaugh D., and Carbone D.P. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3 (1997) 483-490
32. Hillenbrand E.E., Neville A.M., and Coventry B.J. Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours. Br. J. Cancer 79 (1999) 940-944
33. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., and Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188 (1998) 373-386
34. Marucci G., Betts C.M., Golouh R., Peterse J.L., Foschini M.P., and Eusebi V. Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description. Virchows Arch. 441 (2002) 117-123
35. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., Qin S., and Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28 (1998) 2760-2769
36. Sozzani S., Allavena P., D'Amico G., Luini W., Bianchi G., Kataura M., Imai T., Yoshie O., Bonecchi R., and Mantovani A. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161 (1998) 1083-1086
37. Huang F.P., Platt N., Wykes M., Major J.R., Powell T.J., Jenkins C.D., and MacPherson G.G. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191 (2000) 435-444
38. Schuler G., Schuler-Thurner B., and Steinman R.M. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15 (2003) 138-147
39. + dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res. 64 (2004) 2192-2198